# Hemosmartmed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hemosmartmed

- Industry: Medical Devices & Equipment
- Headquarters: Kunshan, China
- Website: www.holosmed.com
- Latest round: Angel (Dec 31, 2018)
- Investors on record: 4

## About

Based in Jiangsu, China and founded in 2018, Hemosmartmed is a medical company that focuses on the development and production of vitro diagnostic microfluidic systems. The company has established virtual R&D centers at Cambridge University and Warwick University. The company has R&D centers in Pudong, Shanghai, and Cambridge, UK, and a production base in Kunshan, Suzhou. In addition, it owns more than 400 independent intellectual property rights and has obtained 55 NMPA registration certificates and 12 EU CE certificates. In November 2024, it closed a venture funding.

At present, the company provides microfluidic control system development and production in the field of in vitro diagnosis as well as microfluidic technical consultancy services. Its business scope includes, automatic microdroplet high-speed production intelligent system, circulating tumor cell rapid screening system, microbial rapid detection kit, trace detection kit for misfolded protein in neurodegenerative diseases, and preparation of microcapsules.

The company generates revenue by providing innovative diagnostic solutions, including automated rapid diagnostic equipment, microfluidic chips, and diagnostic reagent kits.

## Funding rounds

- Angel, Dec 31, 2018 — SND Ventures Group, Kunshan Kersen Science & Technology Co., Ltd, Purple Cow Startups, Innoangel Fund

## Investors

- SND Ventures Group (https://capitalatlas.ai/funds/snd-ventures-group) — Angel
- Kunshan Kersen Science & Technology Co., Ltd — Angel
- Purple Cow Startups (https://capitalatlas.ai/funds/purple-cow-startups) — Angel
- Innoangel Fund (https://capitalatlas.ai/funds/innoangel-fund) — Angel